Follow Us:

MDR CE Marking

Home CE Marking Process
Home › MDR CE Marking Process

MDR CE Marking Process: Steps, Timeline and Responsibilities

The MDR CE marking process takes a medical device from scoping and technical documentation to a notified body certificate under Regulation (EU) 2017/745. Once the notified body agreement is signed, it most often takes 13 to 18 months. This page sets out the 8 steps, a month-by-month timeline and who does what between I3CGLOBAL’s CE marking consultants and the manufacturer.

The basics

What Is the MDR CE Marking Process?

The MDR CE marking process is the project a manufacturer runs to place a medical device on the EU market under the Medical Device Regulation. It covers building the technical documentation, generating test and clinical evidence, submitting to a notified body, answering its questions, passing the quality system audit and receiving the certificate. After that, the manufacturer signs the EU declaration of conformity and affixes the CE marking.

This page looks at the process as a project: the order of the work, how long each stage takes and who delivers each part of the technical file. For the regulatory side, including conformity routes by device class and what a notified body checks, see our MDR CE marking approval flowchart. For full project support, see our medical device CE marking service.

Key facts

MDR CE marking process at a glance

Legal basis
Regulation (EU) 2017/745 (MDR)
Main deliverable
Technical documentation under Annexes II and III
Typical preparation
About 4 months in our plan; manufacturers commonly report 6 to 12 months
Notified body phase
13 to 18 months is the most commonly reported period (Commission survey, data to February 2026)
Review rounds
Plan for two rounds of notified body questions
Final audit
On-site quality management system audit by the notified body
Our benchmark
18 months from the start of documentation to certificate
Step by step

What Are the 8 Steps of the MDR CE Marking Process?

The MDR CE marking process runs in 8 steps: scoping, technical file build, evidence, notified body application, two review rounds, the quality system audit and the certificate. The first three steps sit mostly with the manufacturer and its consultant. The last five depend on the notified body’s schedule as well.

MDR CE marking process in 8 steps from scoping to certificate
1

Scope and gap analysis

Fix the intended purpose, the device classification, the conformity route and the models in scope. A technical file gap analysis shows what already exists and what is missing.

2

Build the technical file

Compile the technical documentation in the Annex II structure: device description, labels and IFU, design and manufacturing, GSPR, risk and post-market documents.

3

Complete the evidence

Close testing gaps such as biocompatibility, electrical safety, sterilisation and shelf life, and finish the clinical evaluation report so every claim is supported.

4

Apply to a notified body

Choose a notified body designated for your device codes, lodge the application and sign the agreement. This often takes one to three months on its own.

5

First review round

The notified body reviews the technical documentation and sends its first list of questions and non-conformities. You answer each one with evidence.

6

Second review round

The notified body checks your answers and raises any remaining points. A well-prepared file closes here without a third round.

7

Quality system audit

The notified body audits your quality management system on site, usually against ISO 13485 and the MDR, and checks that design, production and post-market processes work.

8

Certificate and CE marking

The notified body issues the certificate. You sign the EU declaration of conformity, affix the CE marking, register in EUDAMED and keep the file up to date.

Timeline

How Long Does the MDR CE Marking Process Take?

The MDR CE marking process typically takes about 18 months from the start of documentation to the certificate in I3CGLOBAL projects. That is roughly 4 months of preparation and 14 months with the notified body. The European Commission’s 20th notified bodies survey, with data to 28 February 2026, reports 13 to 18 months as the most common period from signed agreement to certificate.

Timelines drive budgets, launch plans and investor conversations, so it helps to see where the months go. The chart below shows our experience-based plan for a typical class IIa or IIb device. Your plan will move with the device, the state of your evidence and notified body capacity.

StageMonths in our planWhat happens
PreparationM1 to M4Gap analysis, technical file compilation, test plans and clinical evaluation
First reviewM5 to M11Notified body review of the technical documentation, then your answers to its questions
Second reviewM12 to M15Check of your answers and closure of the remaining points
QMS auditM16 to M17On-site audit of the quality management system and closure of any findings
CertificateM18Certificate issued, declaration of conformity signed, CE marking affixed

Before month 1: lodging the application and signing the notified body agreement often takes one to three months. Start this in parallel with preparation so it does not add to the 18 months. Compare notified body fees and our CE certification cost guide when you budget.

Class I devices that are not sterile, do not measure and are not reusable surgical instruments skip the notified body stages. For them, the MDR CE marking process ends when the technical documentation is complete and the declaration of conformity is signed, so the timeline depends on your own preparation.

Delays

What Delays the MDR CE Marking Process, and How Can You Shorten It?

Most delays in the MDR CE marking process come from the manufacturer’s side, not the notified body. Commission surveys have repeatedly found that around 60% of the review time sits with the manufacturer, mostly in preparing answers. That is the part you can control.

Common causes of delay

  • An incomplete application that the notified body cannot accept
  • Clinical evidence that does not support every claim, or a weak equivalence case
  • Gaps between the GSPR checklist and the test reports
  • Different intended purpose, indications or warnings in the IFU, risk file and clinical evaluation
  • Test reports to old standard versions, or missing tests such as biocompatibility or usability
  • Slow or partial answers to notified body questions

How to shorten the timeline

  • Run a gap analysis before you apply, not after the first review
  • Start long tests such as shelf life and biocompatibility early
  • Lodge the notified body application while the file is being finished
  • Keep one intended purpose across every document, with version control
  • Answer each question with evidence and a document reference, within the agreed time
  • Get your QMS audit-ready while the technical review is running
Responsibilities

Who Does What in the MDR CE Marking Process?

In the MDR CE marking process, the manufacturer supplies the device data and stays legally responsible for the technical documentation. I3CGLOBAL scopes, drafts, reviews and compiles it, and liaises with the notified body. The matrix below splits every section of MDR Annex II between the two, in the order a technical file is built.

Several rows change with the device type. Sterile, implantable, active and software-driven devices need different standards and tests, so the matrix notes where expectations differ. For the file structure itself, see our MDR technical documentation table of contents and types of MDR technical files.

Annex II ClauseDescriptionScope of I3CGLOBALScope of Client
Phase 1 – Device Introduction
0INTRODUCTION
  • Provide the overview and structure of the technical file as per the MDR Annex II framework.
  • Define scope of technical documentation
Review and confirm the scope of technical documentation.
0TECHNICAL FILE DETAILS
  • Frame the technical documentation file (TDF).
  • Set up the cloud folder structure and share it with all stakeholders.
Provide internal document control and record control numbers as per EN ISO 13485 procedures.
0REVISION HISTORYPrepare and maintain the TDF revision history template; log changes at every review cycle / update as applicable (Until granting CE)Inform I3CGlobal of any device or changes requiring a new revision entry.
0WARNINGInsert the standard confidentiality/proprietary information notice as per company practice.Confirm the confidentiality classification of the technical file as per EN ISO 13485 / GMP procedure.
0TECHNICAL FILECompile and format the complete technical documentation file (TDF) as per MDR Annex II (both Part A and Part B annexures / supporting evidence).Provide all device-specific source documents and data required for compilation wherever applicable and as per your availability.
0PURPOSEDraft the purpose statement of the TDF with reference to MDR 2017/745.Review and approve the purpose statement.
0SCOPEDefine the scope of the technical file, covering the device models/variants under review.Confirm the exact models, variants and accessories to be included in the scope.
0COMPANY PROFILEReview and update in TDFProvide company profile details – history, facilities, and certifications held.
0LEGAL NAMES AND ADDRESS OF THE MANUFACTURER
  • Verify the manufacturer name and full manufacturing location address against any legal address proof issued by a government / central / state agency.
  • Review the corporate office address if applicable and to be printed on the CE certificate.
  • Provide the manufacturer’s name and registered address with supporting evidence.
  • Provide contact information with the name of the person, designation and email.
0EUROPEAN UNION AUTHORIZED REPRESENTATIVEReview EAR agreement, mandate and EAR SRN details along with PRRC.Confirm the appointment of the EU Authorized Representative and provide the mandate, agreement and SRN
0NOTIFIED BODY
  • Provide guidance on Notified Body selection, ensuring the NB’s designation scope covers the applicable device category, and prepare the section referencing NB details.
  • Submit applications with multiple NBs if not applied
Provide the notified body name, identification number and certificate details (if already engaged).
Phase 2 – Device Description and Specification, Including Variants and Accessories / Components / Modules
1.1aPRODUCT OR TRADE NAMEFormat and insert the product/trade name in the document.Provide the confirmed product/trade name(s).
1.1aGENERAL DESCRIPTION
  • Draft the general description based on inputs, ensuring MDR-compliant language.
  • Compile the device description section from the data supplied.
  • Compile the description of the device housing/enclosure, applicable accessories (e.g., leads, probes, cables) and, where applicable, embedded firmware, and their interoperability at a high level.
  • Review its consistency with the labelling
  • Provide the technical write-up about the device.
  • Provide description of the device housing, accessories, and (where applicable) embedded firmware and their interoperability.
  • Provide information on the intended anatomical/use site and method of use or implantation.
  • Provide details of the device’s operating environment (body contact, MRI conditionality, wireless connectivity, etc., where applicable)
1.1aINTENDED PURPOSE
  • Review and refine the intended purpose statement for MDR compliance.
  • Review its consistency with the labelling
Provide the intended purpose statement of the device.
1.1aINTENDED USERS
  • Format the intended user profile section.
  • Review the intended users based on the intended clinical use and clinical data
  • Review its consistency with the labelling
Identify the intended user group(s) (e.g., healthcare professional, layperson).
1.1bBASIC UDI-DI
  • Guide on basic UDI-DI generation and verify or validate the format the Issuing agency’s guideline
  • Review its consistency with the labelling
Generate and provide the basic UDI-DI via the assigned issuing agency.
1.1cTHE INTENDED PATIENT POPULATION
  • Review the intended patient population based on the intended clinical use and clinical data
  • Review its consistency with the labelling
Provide the intended patient population details.
1.1cMEDICAL CONDITIONS
  • Review the medical conditions based on the intended clinical use and clinical data
  • Review its consistency with the labelling
Provide the medical condition(s) the device is intended to treat, diagnose or monitor.
1.1cINDICATIONS
  • Draft the section format and cross-check consistency with labelling.
  • Review the medical indications on the intended clinical use and clinical data
  • Review its consistency with the labelling
Provide the indications for use.
1.1cCONTRA-INDICATIONSDraft the contraindications based on the labelling requirements from Risk and Clinical Evaluation
  • Provide contraindications, if any.
  • Confirm the listed contraindications
1.1cWARNINGSCross-check warnings against GSPR and labelling requirements from Risk and Clinical EvaluationProvide the list of warnings/precautions associated with device use.
1.1dPRINCIPLE OF OPERATIONDraft/review the principle of operation description for regulatory clarity.Provide the technical explanation of how the device works (mechanism of action).
1.1eMEDICAL DEVICE RATIONALEDraft the rationale for qualifying the product as a medical device under MDR Article 2 or MDCG 2019-11Provide supporting technical/clinical rationale and intended medical purpose evidence.
1.1fDEVICE CLASSIFICATION AND JUSTIFICATIONPerform device classification per MDR Annex VIII and prepare the classification justification/rationale document per MDCG 2021-24, Rev.1; classify embedded firmware safety class per IEC 62304 where applicable.Provide the details required for classification and review/approve the classification.
1.1gEXPLANATION OF NOVEL FEATURESDraft the section highlighting novel design features, materials, or (where applicable) algorithms/AI-ML functions, versus previous/prior-generation versionsIdentify and describe the novel design features, materials, or (where applicable) algorithms/AI-ML functions, versus previous/prior-generation versions
1.1hDESCRIPTION OF THE ACCESSORIESCompile description of accessories (e.g., external programmer/controller, leads, cables, consumables) and their interaction with the device.Provide description of all accessories supplied with or used alongside the device.
1.1iDESCRIPTION OF THE VARIANTSSend a requisition to the client for modules, versions or configurations, if applicable covered in the scope of TDF and prepare the consolidated section as per MDR Annex II, Section 1.
  • Provide the description of all device variants/models and their differences.
  • Provide complete details of the modules, versions or configurations, if applicable
1.1jCOMPONENTS DESCRIPTION WITH DRAWINGS
  • Compile the component description section and insert engineering drawings/diagrams in the required format.
  • Review the housing, connector and (where applicable) electronic assembly drawings and refine according to MDR and, where applicable, IEC 62304 requirements.
  • Provide engineering drawings, exploded views and component descriptions.
  • Provide the electronic/firmware architecture diagram (where applicable) along with SOUP items and configuration components
1.1kDESCRIPTION OF THE RAW MATERIALSReview the raw materials list / Bill of Materials (BOM), including patient-contacting materials.Provide the raw materials list / Bill of Materials (BOM) with material certificates/traceability.
1.1lTECHNICAL SPECIFICATIONSCompile and review the technical specification tables/section.Provide detailed technical specifications (dimensions, weight, materials, performance parameters, power/battery, connectivity, ingress protection, etc. as applicable)
1.2aAN OVERVIEW OF THE PREVIOUS GENERATIONReview the previous versions providedProvide previous released versions in the market
1.2bAN OVERVIEW OF EQUIVALENT OR SIMILAR DEVICESAssist in identifying equivalent and similar devices and list them, with comparisons based on high-level technical specifications.Provide technical and clinical information of the equivalent/similar device (if the equivalence route is pursued).
Phase 3 – Information to be Supplied by the Manufacturer
2LABELSReview label and symbol content against MDR labelling requirements (Annex I, 23.1–23.4) and ISO 15223-1 symbols; provide corrections.Provide the content of all device labels and its deployment information
2IFUReview IFU content against MDR Annex I check requirements, risk, clinical and applicable standards and provide corrections.Provide the draft Instructions for Use in all required languages.
Phase 4 – Design and Development Information
3aDESCRIPTION OF THE DESIGNCompile and review the device design description/design controls summary, covering mechanical, electronic (where applicable) and firmware (where applicable) design, and the development plan.
  • Provide design file extracts/design description as per ISO 13485 design control requirements (and IEC 62304 where firmware is present).
  • Provide the device development plan
3bMANUFACTURING PROCESSESReview the manufacturing process flow and methodology sharedProvide the manufacturing process flow, methodology and process validation records (IQ/OQ/PQ) used for production
3bFINAL PRODUCT SPECIFICATION AND TESTING
  • Compile the final product release specification and testing section.
  • Compile/review the final acceptance/release test reports.
  • Provide final product/release specifications and QC test records.
  • Provide final acceptance test reports (and firmware release notes, where applicable).
3bMANUFACTURING ENVIRONMENTAL CONTROLSFormat the manufacturing environment/cleanroom controls section and cross-check against applicable standards.Provide details of cleanroom classification (where applicable), environmental monitoring and contamination controls used in manufacturing
3cSUPPLIERS AND SUBCONTRACTORSReview the BOM and list the suppliers and subcontractors
  • Provide the list of critical suppliers/subcontractors, their roles and certificates (e.g., ISO 13485).
  • Provide the BOM
Phase 5 – General Safety and Performance Requirements (GSPR)
4THE GENERAL SAFETY AND PERFORMANCE REQUIREMENTSComplete the GSPR checklist, referencing supporting evidence/documents, and identify gaps.Provide test reports, standards compliance data and technical justifications for each GSPR.
4DECLARATION OF CONFORMITYPrepare the Declaration of Conformity as per MDR Annex IV.Review and sign the Declaration of Conformity.
4c, 4dLIST OF APPLICABLE LEGISLATIONIdentify and compile the list of applicable EU legislationConfirm any additional national/regional legislation applicable to the device.
4c, 4dLIST OF APPLICABLE GUIDELINESIdentify and compile applicable MDCG guidance documents.Review and confirm the applicability of the listed guidelines.
4c, 4dLIST OF APPLICABLE HARMONIZED STANDARDSIdentify applicable harmonized standards (per the EU Official Journal) and compile the list.Confirm standards tested against and provide certificates of compliance.
4c, 4dLIST OF APPLICABLE NON-HARMONIZED STANDARDSIdentify relevant non-harmonized / state-of-the-art standards applicable to the device.Confirm any additional standards followed and provide supporting test reports.
Phase 6 – Benefit-Risk Analysis and Risk Management
5aTHE BENEFIT-RISK ANALYSISPrepare/review the benefit-risk analysis and methodology as per Annex I, Chapter I.Provide clinical/technical data supporting the benefit-risk determination.
5bRISK MANAGEMENTReview the risk management file against ISO 14971 (and IEC 62304 / ISO/IEC 27001 / MDCG 2019-16 where firmware or connectivity is present); identify gaps and provide corrective guidance.Conduct the risk management activities and provide the complete risk management file (plan, analysis, evaluation, control, and report).
Phase 7 – Verification and Validation
6.1aPRE-CLINICAL SAFETYReview pre-clinical safety/bench data (and VAPT reports where the device is networked/wireless) for completeness against the GSPR.Provide pre-clinical bench test reports and, where applicable, Vulnerability Assessment & Penetration Testing (VAPT) reports.
6.1bBIOCOMPATIBILITY OF THE DEVICEReview the biocompatibility evaluation/testing against the ISO 10993 series for all patient-contacting materials and identify gaps.Provide biocompatibility test reports/biological evaluation per ISO 10993-1 for all body-contacting materials.
6.1bELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITYReview electrical safety and EMC test reports against the applicable IEC 60601 series (and ISO 14708 series where relevant) and identify gaps.Provide electrical safety and EMC test reports per the applicable IEC 60601 series (and ISO 14708 particular standard where relevant).
6.1bSOFTWARE / FIRMWARE VERIFICATION AND VALIDATIONReview software/firmware V&V documentation against IEC 62304 and MDR requirements; provide gap analysis.Provide software/firmware development lifecycle documentation, verification/validation test plan & reports and the software safety & security risk management file.
6.1b, 6.2eSTERILIZATIONReview the sterilization validation (method, dose/cycle, SAL) against ISO 11135 / ISO 11137 / ISO 17665 as applicable and identify gaps.Provide sterilization validation reports (method, SAL 10⁻⁶ demonstration) per the applicable ISO 11135/11137/17665 standard.
6.1bSTABILITYReview shelf-life/aging (and, where applicable, battery longevity) stability data and identify gaps.Provide shelf-life (real-time and accelerated aging) test reports, and battery longevity/stability data where applicable.
6.1cCLINICAL EVALUATIONPrepare/review the Clinical Evaluation Report (CER) as per MEDDEV 2.7/1 Rev.4 and MDR and MDCG 2020-1 requirements.Provide clinical data, literature search inputs and post-market clinical follow-up (PMCF) data as available.
6.1dPOST-MARKET ACTIVITIESPrepare/review the PMS plan, PMS report/PSUR and PMCF plan templates.Provide post-market surveillance data, complaints, vigilance reports and PMCF data.
6.1d,6.2ePACKAGING AND TRANSPORTATIONReview packaging (sterile barrier where applicable) and transport/shipping validation against the applicable standards and identify gaps.Provide packaging validation (ISO 11607-1/-2 where sterile) and transport/shipping simulation test reports.
6.2aMEDICINAL PRODUCTS WITHIN THE MEANING OF DIRECTIVE 2001/83/ECNot Applicable, unless the device incorporates a medicinal substance (e.g., a drug-eluting component).Not Applicable, unless the device incorporates a medicinal substance.
6.2bTISSUES OR CELLS OF ANIMAL ORIGINNot Applicable, unless the device incorporates animal-derived materials.Not Applicable, unless animal-derived materials are used.
6.2cDEVICES THAT ARE COMPOSED OF SUBSTANCES OR COMBINATIONS OF SUBSTANCESNot Applicable, unless the device is absorbed by or locally dispersed in the human body.Not Applicable, unless applicable to the device design.
6.2dCMR OR ENDOCRINE-DISRUPTING ACTIVITYReview device materials against MDR Annex I, Section 10.4 for CMR/endocrine-disrupting substances present above 0.1% w/w and prepare justification if present.Provide a full material declaration and justification for any CMR/endocrine-disrupting substances present above 0.1% w/w.
6.2eSTERILIZATIONCross-reference the sterilization validation summary compiled under Section 6.1.5.Confirm sterilization method and validation status.
6.2fMEASURING FUNCTIONPartially Applicable – where the device includes a measuring/sensing function, it is evaluated under device verification & validation. Review the accuracy/metrological verification data.Provide accuracy/metrological verification data.
6.2gCOMBINATION WITH OTHER DEVICESPartially Applicable – interfaces with accessories/consumables or connected devices are evaluated under device verification & validation. Review the list of interfaces/accessories.Provide details of the interfaces/accessories connected to or used with the device.
0MANUFACTURER DECLARATIONPrepare the manufacturer declaration template for the specific-case section.Review and sign the manufacturer declaration.
Phase 8 – Conclusion and Approval
0CONCLUSION AND APPROVALPrepare the final review summary and compile the complete technical file for client approval.Perform the final review and provide sign-off/approval of the technical documentation.

The result is a technical file that is complete, internally consistent and structured the way assessors expect. If you want ready-made structures, see our MDR technical file templates.

Checklist

What Should You Prepare Before Starting the MDR CE Marking Process?

Have these inputs ready before the MDR CE marking process starts. Each one is a source document that only the manufacturer can provide, and a missing item is the most common reason the preparation stage runs late.

  • Device description, intended purpose, intended users and patient population
  • Models, variants, accessories and the product or trade names
  • Engineering drawings, bill of materials and material certificates
  • Manufacturing process flow, process validation records and critical suppliers
  • Labels and instructions for use, and a plan for MDR labelling in the required languages
  • Test reports: electrical safety and EMC, biocompatibility, sterilisation validation, packaging, shelf life and software, where relevant
  • Risk management file, usually following ISO 14971 (see medical device risk management)
  • Clinical data and literature for the clinical evaluation, plus any PMCF data
  • Quality management system records, usually under ISO 13485
  • Your EU authorised representative mandate and PRRC details, if you are outside the EU
  • Basic UDI-DI from your issuing agency (see UDI system)

Want a realistic plan for your device?

Our CE marking consultants review your product profile and map the MDR CE marking process phase by phase and month by month.

FAQs

MDR CE Marking Process: Frequently Asked Questions

How long does the MDR CE marking process take?

In I3CGLOBAL projects, the MDR CE marking process takes about 18 months from the start of documentation to the certificate. The European Commission’s 20th notified bodies survey, with data to 28 February 2026, reports 13 to 18 months as the most common period from signed notified body agreement to certificate.

What is the difference between the CE certification process and CE marking?

The CE certification process is the notified body’s assessment, which ends with an MDR certificate. CE marking is the step that follows: the manufacturer signs the EU declaration of conformity and affixes the CE mark, with the notified body number where one was involved.

How many notified body review rounds should I expect?

Plan for two rounds of questions on the technical documentation. A complete, consistent file can close in two rounds. Gaps in clinical evidence or testing often lead to a third round, which adds months to the MDR CE marking process.

Does a class I device follow the same MDR CE marking process?

Not fully. A class I device that is not sterile, does not measure and is not a reusable surgical instrument needs no notified body. The manufacturer prepares the technical documentation, signs the declaration of conformity and registers in EUDAMED. Class Is, Im and Ir devices need a notified body for those aspects only.

What does the manufacturer need to provide?

The manufacturer provides the source data: device description and intended purpose, drawings and bill of materials, manufacturing information, test reports, the risk management file, clinical data, labels and instructions for use, and quality system records. The consultant drafts, reviews and compiles these into the technical file.

Who is responsible for the technical documentation?

The manufacturer is legally responsible for the technical documentation under the MDR, even when a consultant prepares it. In our projects, I3CGLOBAL drafts, reviews and compiles each Annex II section, and the manufacturer supplies the data, reviews and signs off.

Can the MDR CE marking process be done faster?

Yes, mainly on the manufacturer’s side. Run a gap analysis before applying, start long tests early, apply to the notified body in parallel with preparation and answer every question with evidence. Notified body queue time cannot be shortened, but a complete file avoids extra review rounds.

What happens after the CE certificate is issued?

The manufacturer signs the EU declaration of conformity, affixes the CE marking and completes EUDAMED registration. MDR certificates are valid for up to five years, with surveillance audits at least every 12 months, plus post-market surveillance, vigilance and change control.